2027 OPPS and ASC final rule: Key changes reshaping outpatient care

Payment, reimbursement, authorization, and site-of-care requirements are shifting. Here’s what health systems should know for 2027 and beyond.
Published
Written by
Picture of Shelly L. Jude, RHIA, RHIT, HIT
Global Clinical Services Director

The Centers for Medicare & Medicaid Services (CMS) has finalized updates to the Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System for calendar year 2027. The rules would affect approximately 3,500 hospitals and 6,400 ASCs and include changes to payment rates, site-of-service policies, drug reimbursement, prior authorization, and quality reporting.  

As outpatient care evolves, health systems are navigating increasingly complex requirements around where procedures are performed, how they are reimbursed, and what is required to support them. 

Below, we outline six key changes health systems should prepare for. 

1. 2027 OPPS and ASC payment update 

CMS finalized a 2.3% payment-rate increase for hospitals that meet applicable quality reporting requirements. Qualifying ASCs would receive the same update. The rule is based on a projected 3.2% hospital market basket increase, reduced by a 0.9 percentage-point productivity adjustment.  

2. Continued phaseout of the inpatient-only list 

CMS is continuing its three-year phaseout of the Inpatient Only (IPO) list. For 2027, the agency is proposing to remove 637 additional services across clinical families including digestive, endocrine, respiratory, urinary, integumentary, maternity and delivery, and others.  

The change allows Medicare to pay for these services in the hospital outpatient setting when clinically appropriate, giving physicians greater flexibility in determining the appropriate site of care.  

The rule follows the removal of 285 codes finalized for 2026, marking the first year of the phase-out.  

As more procedures become eligible for outpatient care, health systems need to keep scheduling, authorization, and reimbursement workflows aligned with changing site-of-care policies.  

3. Expansion of site-neutral payments 

CMS finalized an expansion of site-neutral payment policies, applying Physician Fee Schedule-equivalent rates to certain imaging services without contrast – including X-rays, ultrasound, CT scans, and MRIs – performed at excepted off-campus provider-based departments. Rural Sole Community Hospitals are exempt. 

CMS estimates the change would reduce Medicare Part B expenditures by approximately $260 million in the first year.  

Building on earlier policies affecting clinic visits and drug-administration services, the final rule reflects CMS’s continued efforts to reduce payment differences based on where care is delivered. 

4. Changes to 340B drug reimbursement 

The final rule also includes significant changes for hospitals participating in the 340B Drug Pricing Program. 

Based on a 2026 hospital drug acquisition cost survey, CMS finalized reimbursement for 340B-acquired drugs at Average Sales Price (ASP) minus 28%. The agency estimates this would reduce Original Medicare drug payments by $4.35 billion and beneficiary payments by $1.1 billion in the first year. To maintain budget neutrality, CMS will increase OPPS payments for non-drug services by an equivalent amount. 

CMS also finalized an increase in the existing 340B remedy offset by increasing the reduction to the OPPS conversion factor for affected non-drug services from 0.5% to 2% beginning in 2027. The agency estimates this would achieve the targeted $7.8 billion reduction by 2031.  

Together, these rules could significantly affect outpatient reimbursement for participating hospitals. 

5. Expansion of prior authorization requirements 

CMS finalized the addition of eight botulinum toxin injection codes to its prior authorization requirements for hospital outpatient departments, citing utilization increases and program-integrity concerns.  

For providers, the change underscores the importance of maintaining accurate, up-to-date procedure codes and identifying applicable authorization requirements before procedures are performed to help reduce avoidable delays and reimbursement risk. 

6. Quality reporting changes for hospitals and ASCs 

CMS finalized changes to the Hospital Outpatient Quality Reporting (OQR) and ASC Quality Reporting (ASCQR) programs. 

One change removes the Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients measure from both programs beginning with the CY 2027 reporting period for the CY 2029 payment determination. CMS notes that another existing colonoscopy measure is more closely tied to clinical outcomes.  

Quality reporting also carries financial implications. Hospitals and eligible ASCs that fail to meet applicable reporting requirements may receive a two-percentage-point reduction to their annual payment-rate update. 

7. New payment for software-based diagnostic services 

CMS finalized a terminology change from Software as a Service (SaaS) to Software as a Medical Service (SAMS) for software-based technologies used to diagnose disease and support clinical decision-making. These services will be assigned to new technology Ambulatory Payment Classifications (APCs) as CMS develops a broader payment policy. 

The rule also moves payment for certain standalone algorithmic analyses performed on data from prior laboratory tests from the Clinical Laboratory Fee Schedule (CLFS) to the OPPS, where they will be paid as other diagnostic tests. 

For health systems, these changes reinforce the importance of maintaining accurate procedure codes and terminology as new diagnostic technologies enter outpatient workflows and reimbursement structures.  

What these changes mean for health systems 

Taken together, the finalized policies underscore a common challenge: health systems must keep pace with evolving requirements for where procedures are performed, authorized, and reimbursed. 

Accurate surgical data is critical to navigating these changes. 

As outpatient care evolves, health systems need reliable terminology and coding to support appropriate site-of-care decisions, consistent clinical workflows, and reimbursement accuracy.  

IMO Health helps health systems navigate this complexity through standardized surgical terminology and maintained procedural content, including CPT and HCPCS codes. Its perioperative offering includes IPO-list and ASC-inclusive code identification to support scheduling, prior authorization, and revenue tracking as CMS policies evolve. 

Gearing up for 2027? Make OPPS and ASC readiness part of the plan. Talk with an IMO Health expert about how standardized procedural data can help. 

CPT is a registered trademark of the American Medical Association. All rights reserved.

Related Content

Latest Resources​

Discover how IMO Health and Inovalon are partnering to turn complex healthcare data into actionable insights through deeper clinical intelligence.
Discover how IMO Health's Knowledge Graph is helping Gemini achieve more accurate, consistent results.
How health systems can standardize source data, manage clinical definitions, and extract usable information from text to support analytics, quality, and AI.
ICYMI: BLOG DIGEST

The latest insights and expert perspectives from IMO Health

In your inbox, twice per month.